Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma

This imaging study tests a new PET scan tracer called 68Ga-PentixaFor to better detect and track multiple myeloma — a cancer of the blood plasma cells — at the time of first diagnosis. Researchers hope this scan can reveal cancer that other scans might miss. **You may be eligible if...** - You are 18 or older - You have been newly diagnosed with symptomatic multiple myeloma requiring treatment - You are enrolled in the French national health service - You are in good functional health (ECOG below 2) **You may NOT be eligible if...** - You have HIV, active hepatitis B or C - You are pregnant or breastfeeding, or not using adequate contraception - Your kidney function is significantly reduced - You have another active cancer - You have uncontrolled diabetes - You are under legal guardianship Talk to your doctor to see if this trial is right for you.